IL2 and neoplasm: Recent research involving the treatment of NK cells with IL-2/HSP70 stimulated BBB crossing and the subsequent antitumor effects of NK cells and resulted in a substantial tumor growth inhibition and prolonged survival in an in vivo study [32].